Does upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis?

scientific article published in September 2017

Does upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis? is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID29135095

P2093author name stringJohn Spiliotis
Nikolaos Kopanakis
Elias Efstathiou
Dimitrios Sarris
P433issue5
P921main subjectperitoneal carcinomatosisQ2071182
P304page(s)1144-1147
P577publication date2017-09-01
P1433published inJournal of B.U.ON. : official journal of the Balkan Union of OncologyQ27721148
P1476titleDoes upfront therapy with cytoreductive surgery and HIPEC confer a survival benefit in patients with synchronous gastric peritoneal carcinomatosis when compared with patients with metachronous gastric peritoneal carcinomatosis?
P478volume22

Search more.